Chinese medicinal preparation for treating myocardial infarction and preparation method thereof

Abstract

The invention discloses a Chinese medicinal preparation method for treating myocardial infarction and a preparation method thereof, belonging to the field of traditional Chinese medicine. The active ingredients of the Chinese medicine preparation are prepared from the following raw materials: Chinese hibisci rosae-sinensis flower, lily, flat-stemmed tetrastigma, cudrania root, sedum aizoon, manyflower glorybower root, bunge corydalis herb, clematis filamentosa dunn, rhizoma paridis, sea clam shell, celery, allium macrostemon, sophora flower, alocasia macrorrhiza, suberect spatholobus stem and lightyellow sophora root. The Chinese medicinal preparation is prepared from medicinal raw materials which are matched reasonably, complies with the theories of the traditional Chinese medicine and pharmacy as well as modern medicine and pharmacology, has the effects of relieving blood vessels, protecting myocardium, alleviating pain, diminishing inflammation, reinforcing qi and nourishing blood, has a remarkable curative effect on myocardial infarction and the like, and has the advantages of good adsorption effect, long-lasting effect, safety, reliability and no toxic or side effects. Moreover, the Chinese medicinal preparation is convenient to take and low in cost, contributes to reduction of the economic burden of patients, and can be widely applied to clinical treatment of myocardial infarction.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation for treating myocardial infarction and a preparation method thereof. Background technique [0002] Myocardial infarction is myocardial necrosis caused by acute and persistent coronary ischemia and hypoxia. Clinically, there are often severe and persistent substernal pains, which cannot be completely relieved by rest and nitrates, accompanied by increased serum myocardial enzyme activity and progressive ECG changes, which may be complicated by arrhythmia, shock or heart failure, often life-threatening. The disease is most common in Europe and the United States, and about 1.5 million people in the United States suffer from myocardial infarction every year. China has shown a clear upward trend in recent years, with at least 500,000 new cases and at least 2 million existing cases each year. [0003] Most patients occur on the b...

AI Technical Summary

Problems solved by technology

[0010] At present, the drugs for the treatment of myocardial infarction are mainly based on western medicine, but western medicine can only relieve symptoms, lack of means for pathological treatment, and are prone to recurrence

In recent years, although both at home and abroad have tried to use traditional Chinese medicine to treat myocardial infarction, they have not made great progress. Some traditional Chinese medicines have certain curative effects on the treatment of myocardial infarction, but they cannot be cured, and the recurrence rate is high; in order to develop a Drugs that can effectively treat myocardial infarction have attracted great attention from major hospitals